💊 Médicaments A-Z 🧬 Cibles 🛠 Outils 📚 Guides
Tous les médicaments Classes de médicaments Aires thérapeutiques Effets Indésirables
Guides Glossaire Chronologie
Comparaisons Parcours des médicaments Familles de médicaments
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Mequinol

CHEMBL544 Phase 4 Approuvé Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
124.1 g/mol
LogP
1.3
Phase
4

Used to treat certain skin conditions such as solar lentigines (age spots), this medication works by inhibiting melanin production to lighten darkened areas of skin. It is applied directly to the affected skin and is often combined with tretinoin to enhance its effectiveness.

Masse moléculaire

124,1400 g/mol

LogP

1,30

TPSA

29,50 Ų

Règle des 5 de Lipinski

Conforme

Mécanisme d'action

Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.

Structure 2D

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
COc1ccc(O)cc1

                

                

                
                

                    
InChI

                    
InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3

                

                

                

                    
                    

                        
Molecular Formula

                        
C7H8O2

                    

                    
                    

                        
HBD / HBA

                        
1 / 2

                    

                    
                    

                        
Liaisons Rotatives

                        
1

                    

                    
                    
                    

                        
Atomes Lourds

                        
9

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Foire aux questions

                

                    
                    

                        
                        

                            
Used to treat certain skin conditions such as solar lentigines (age spots), this medication works by inhibiting melanin production to lighten darkened areas of skin. It is applied directly to the affected skin and is often combined with tretinoin to enhance its effectiveness.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.

                        

                    

                    

                    

                    

                        
                        

                            
Yes, Mequinol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL544.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 9015.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Avertissement médical

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.